1. Acute and Chronic Renal Failure By Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College

4. ACUTE RENAL FAILURE

5. AKI: O It is sudden and usually reversible loss of kidney function which develops over days or weeks and usually accompanied by reduction of urine volume. O Rise of serum creatinine may be : ---acute injury ------acute on chronic kidney disease.

6. Causes of AKI:

9. Symptoms of ARF : O c/p in volume overloaded patient.

10. Pulmonary edema x-ray

11. O c/p of O Dehydrated man with -Sunken eyes, -Dry mouth, -Loss of skin turgor, -oliguria

13. Hyperkalemia symptoms: O Weakness O Lethargy O Muscle cramps O Paresthesias O Dysrhythmias

15. Investigations of patients with AKI: A. Confirmation of AKI: urea and creatinine. B. Complications:- electrolytes : k, calcium and phosphate - anemia: CBC -ECG C. Cause of renal failure: urine analysis, urine C&S, CRP, Abdominal u/s, renal biopsy. CPK D. Serology : HIV & hepatitis serology if urgent dialysis is indicated

17. MANAGEMENT OF AKI: 1-Hemodynamic status : correct hypovolemia and optimise systemic hemodynamics with inotropes if necessary. O 2-Hyperkalemia : O Calcium gluconate (carbonate) for counteracting effect on the heart O Sodium Bicarbonate O Insulin/glucose O Kayexalate ( oral cation exchange resin) O Lasix O Albuterol(beta agonist) O Hemodialysis.

18. 3- Acidosis: sodium bicarbonate if PH<7 4-Cardiopulmonary complications:( pulmonary edema): -dialysis - massive diuresis 5-electrolytes disturbance 6-fluid management : match intake to output (with 500ml for insensible losses). 7-discontinue nephrotoxic drugs and reduce dose of medications according to renal function level. 8- Ensure adequate nutritional support

19.  Treatment of any intercurrent infections.  -PPIfor reduction of upper GIT bleeding risk. O Treatment of the primary cause e.g steroids and immunosuppressives in cases of crescentic GN. O Surgical relieve of obstructions O Dialysis may be needed : - hemodialysis -CRRT. - Peritoneal dialysis.

21. Chronic Renal Failure

22. Stages of CKD: GFR (ml/min/1.73 m 2 ) descriptionsta ge  90Kidney Damage with Normal or  GFR 1 60-89 Kidney Damage with Mild  GFR 2 30-59 Moderate  GFR 3 15-29 Severe  GFR 4 < 15 or DialysisKidney Failure 5

23. Common causes of ESRD:  Diabetes mellitus 20-40%  Interstitial diseases 20-30%  Hypertension 5-20%  Glomerular diseases 10-20%  systemic inflammatory diseases (SLE, Vasculitis) 5-10%  Congenital and inherited 5%  Unknown 5-20%

24. Clinical picture and complications

27. Investigations in CKD: O Urea and creatinine O Urine analysis and urine quantification O K and PH O Calcium, phosphorus,PTH and 25(OH)D O Albumin O CBC,IRON PROFILE O U/S O Hepatitis and HIV

28. Management: O Treatment of the underlying condition if possible: O Aggressive blood pressure control to target values <130/80 better by ACEI or ARBs especially in diabetic kidney disease and proteinuria. O Treatment of hyperlipidemia to target levels per current guidelines O Aggressive glycemic control per the American Diabetes Association (ADA) recommendations (target hemoglobin A1c [HbA1C] < 7%) O Avoidance of nephrotoxins, including intravenous (IV) radiocontrast media, (NSAIDs), and aminoglycosides

29. O management of protein intake O Vitamin D supplementation: synthetic vitamin D analogue, is for the prevention and treatment of secondary hyperparathyroidism associated with CKD stage 5. O Anemia: When the hemoglobin level is below 10 g/dL, treat with an erythropoiesis-stimulating agent (ESA). Also ttt of iron deficiency by oral or intravenous iron. The goal is a hemoglobin level of 10-12 g/dL

30. O Hyperphosphatemia: Treat with dietary phosphate binders (eg, calcium acetate, sevelamer carbonate, lanthanum carbonate)and dietary phosphate restriction O Hypocalcemia: Treat with calcium supplements with or without calcitriol O Hyperparathyroidism: Treat with calcitriol, vitamin D analogues, or calcimimetics O Volume overload: Treat with loop diuretics or ultrafiltration O Metabolic acidosis: Treat with oral alkali supplementation O Uremic manifestations: Treat with long-term renal replacement therapy (hemodialysis, peritoneal dialysis, or renal transplantation) O Cardiovascular complications: Treat as appropriate O Growth failure in children: Treat with growth hormone

31. Dialysis ABSOLUTE Indications of DIALYSIS: I. HYPERKALEMIA >7mEq/l II. ACIDOSIS: ph <7.1 and bicarbonate <12 III. FLUID OVERLOAD AND PULMONARY EDEMA IV. SEVERE UREMIA WITH PERICARDITIS V. UREMIC ENCEPHALOPATHY, seizures,coma. OTHER INDICATIONS:

32. Hemodialysis Peritoneal dialysis

33. Renal transplantation: